VLX electroporation system and consumables

GoodsAward procedure without prior publication of a call for competition

Awarded value£600,000published contract · exc. VAT

Awarded 1 Mar 2021no call for competition

Awarded to MaxCyte

What is being bought

Published requirement description

Supply of a VLX electroporation system including consumables, maintenance and repairs.

CPV: Miscellaneous evaluation or testing instruments

single lot · no lot value published

Lot #1Awarded

Delivery: UK

From the official record

Procedure method: Award procedure without prior publication of a call for competition
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 21 Apr 2021, 16:39 BST
Last source update: 21 Apr 2021, 16:39 BST
Authority reference: 1993-S
FTS notice number: 2021/S 000-008530
Classification (CPV): Miscellaneous evaluation or testing instruments
Delivery area: UK
Official registry OCID: ocds-h6vhtk-02a8c3 Find a Tender

Why no open competition: The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons
Published justification: We have received the GOL from UKRI stating that the Maxcyte VLX system must be used.
Our role in this project is to optimise a process that has already been defined and tested between Oxford University, Maxcyte and Absolute Antibody. The Maxcyte equipment has to be used otherwise we would be changing the process, which we cannot do. The project needs to finish by March and if we use a piece of equipment that none of the partners are familiar with it will cause delays.
Our account manager at Maxcyte has also confirmed that they're the sole provider of Maxcyte products in the UK, as well as providing a supporting document stating why only Maxcyte products should be used with the VLX system.

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £600,0001 contract exc. VAT

Bids received 1

Contracts signed 1latest 1 Mar 2021

Awarded to	Value	Date	Status
MaxCyte	£600,000 †	—	Awarded

Contracts

VLX electroporation system and consumables · MaxCyte
Signed
1 Mar 2021
Value
£600,000
Status
active

Bid statistics published by the authority

Lot	Bids	SME	VCSE	Valid bid range
Supply of a VLX electroporation system including consumables, maintenance and repairs	1bids	—	—	—
Whole notice	—	—	—	£400,000 – £600,000

Contracting authorityPublic bodyBody governed by public lawResearch and development Wilton, REDCAR, UK, TS104RFContact name, email, phone

Dispute resolution & review bodies

1 commercial party on the notice

MaxCyteAwarded supplier 22 Firstfield Road, Suite 110, Gaithersburg, MD 20878, Gaithersburg, US

Official links; attachments are not copied

No document links were published on the notice.